EYPT
EyePoint Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.33%Margins
Gross margin
41.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
-9726.7%
-184.3%
Return on equity
-134.4%
Return on assets
-167.9%
Return on invested capital
0.01x
Asset turnover
-$267.3M
Cash from operations
$2.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026